Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
BNP Paribas Arbitrage SA boosted its stake in shares of Adverum Biotechnologies by 426.8% during the 2nd quarter.
BNP Paribas Arbitrage SA increased its position in shares of Tempur Sealy International by 0.3% during the 2nd quarter.
BNP Paribas Arbitrage SA increased its stake in Fidelity D & D Bancorp by 180.4% during the 2nd quarter.
BNP Paribas Arbitrage SA lifted its holdings in Ameren by 13.2% in the second quarter.
BNP Paribas Arbitrage SA now owns 10,437 shares of the company’s stock valued at $74,000 after purchasing an additional 10,195 shares during the period.
BNP Paribas Arbitrage SA now owns 221,352 shares of the utilities provider’s stock valued at $20,001,000 after acquiring an additional 25,759 shares during the period.
BNP Paribas Arbitrage SA now owns 3,135 shares of the utilities provider’s stock valued at $41,000 after purchasing an additional 1,803 shares during the last quarter.
BNP Paribas Arbitrage SA now owns 5,616,766 shares of the pipeline company’s stock worth $62,852,000 after acquiring an additional 919,979 shares during the period.
BNP Paribas Arbitrage SA now owns 625 shares of the bank’s stock worth $31,000 after acquiring an additional 381 shares in the last quarter.
BNP Paribas Arbitrage SA raised its position in shares of Arcturus Therapeutics by 63.4% during the second quarter.
BNP Paribas Arbitrage SNC boosted its position in MGE Energy by 5.9% in the 3rd quarter.
BNP Paribas Arbitrage SNC bought a new position in Aura Biosciences in the 3rd quarter valued at $105,000.
Source: https://www.etfdailynews.com/2023/04/01/aura-biosciences-inc-nasdaqaura-short-interest-update/
BNP Paribas Arbitrage SNC cut its holdings in shares of Vericel Co. () by 46.9% in the second quarter, reports.
BNP Paribas Arbitrage SNC grew its holdings in shares of Fidelity D & D Bancorp by 13,488.9% in the 2nd quarter.
BNP Paribas Arbitrage SNC grew its stake in Cambium Networks by 19.3% in the third quarter.
BNP Paribas Arbitrage SNC now owns 11,062 shares of the biotechnology company’s stock valued at $74,000 after purchasing an additional 10,946 shares during the last quarter.
BNP Paribas Arbitrage SNC now owns 32,200 shares of the specialty chemicals company’s stock worth $1,935,000 after buying an additional 16,553 shares during the last quarter.
BNP Paribas Arbitrage SNC owned 0.09% of Exelon worth $32,594,000 as of its most recent SEC filing.
BNP Paribas Arbitrage SNC purchased a new stake in shares of VanEck Intermediate Muni ETF during the second quarter worth approximately $31,000.
BNP Paribas Arbitrage SNC’s holdings in Autoliv were worth $1,193,000 at the end of the most recent reporting period.